Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension
NG Vallianou, D Kounatidis, F Panagopoulos… - Current Hypertension …, 2023 - Springer
Abstract Purpose of Review The role of the gut microbiota in modulating blood pressure is
increasingly being recognized, currently. The purpose of this review is to summarize recent …
increasingly being recognized, currently. The purpose of this review is to summarize recent …
Diagnostic value of soluble urokinase‐type plasminogen activator receptor in patients with acute coronary syndrome: A systematic review and meta-analysis
M Pruc, I Jannisz, D Swieczkowski… - Cardiology …, 2023 - journals.viamedica.pl
Background: In contemporary clinical practice, there is an increasing need for new clinically
relevant biomarkers potentially optimizing management strategies in patients with suspected …
relevant biomarkers potentially optimizing management strategies in patients with suspected …
Soluble urokinase plasminogen activator receptor: From biomarker to active participant in atherosclerosis and cardiovascular disease
Atherosclerosis contributes to the majority of deaths related to cardiovascular disease
(CVD). Recently, the nonspecific inflammatory biomarker soluble urokinase plasminogen …
(CVD). Recently, the nonspecific inflammatory biomarker soluble urokinase plasminogen …
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease
Soluble urokinase plasminogen activator receptor (suPAR) is a risk factor for kidney
diseases. In addition to suPAR, proteolysis of membrane-bound uPAR results in circulating …
diseases. In addition to suPAR, proteolysis of membrane-bound uPAR results in circulating …
Immune activation mediates the Association of Advanced Hepatic Fibrosis with Adverse Outcomes in patients with coronary artery disease
Background Literature suggests a bidirectional association between advanced hepatic
fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with …
fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with …
Gut microbiome and cardiometabolic comorbidities in people living with HIV
M Trøseid, SD Nielsen, I Vujkovic-Cvijin - Microbiome, 2024 - Springer
Background Despite modern antiretroviral therapy (ART), people living with HIV (PLWH)
have increased relative risk of inflammatory-driven comorbidities, including cardiovascular …
have increased relative risk of inflammatory-driven comorbidities, including cardiovascular …
Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study
CG Hutten, K Padalia, A Vasbinder… - The Journal of …, 2024 - academic.oup.com
Context Obesity is a risk factor for coronavirus disease 2019 (COVID-19)-related outcomes;
however, the mechanism remains unclear. Objective The objective of this analysis was to …
however, the mechanism remains unclear. Objective The objective of this analysis was to …
Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes
V Rotbain Curovic, MB Houlind… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To evaluate the effect of four different drug classes on soluble urokinase plasminogen
activator receptor (suPAR), a biomarker active in multiple inflammatory processes and a risk …
activator receptor (suPAR), a biomarker active in multiple inflammatory processes and a risk …
Venous thromboembolic disease genetics: from variants to function
M Underwood, C Bidlack, KC Desch - Journal of Thrombosis and …, 2024 - Elsevier
Venous thromboembolic disease (VTE) is a prevalent and potentially life-threatening
vascular disease including both deep vein thrombosis and pulmonary embolism. This …
vascular disease including both deep vein thrombosis and pulmonary embolism. This …
Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease
Abstract Purpose of Review Patients with established coronary artery disease (CAD) are at
high residual risk for adverse events, despite guideline-based treatments. Herein, we aimed …
high residual risk for adverse events, despite guideline-based treatments. Herein, we aimed …